[2] Chang CH, Tsai WC, Hsu YH, Pang JH
Prices vary widely depending on insurance coverage, medication, and pharmacy location
A prespecified analysis of pooled data from the STEP-HFpEF and STEP-HFpEF DM trials demonstrated that significantly more patients treated with Wegovy 2.4 mg SC once weekly had an improvement of at least one New York Heart Association (NYHA) functional class compared to those who received placebo (32.6% versus 21.5%, respectively
These are the licensed clinicians who review your intake, decide whether treatment is clinically appropriate, and make all prescribing decisions independently - Luvo Health does not direct or control those decisions, per the brand's disclosures
Now access to those medications is anything but certain.
What is a Compounding Pharmacy